Trial Information

Summary: Prostate Cancer Outcomes by Race and Treatment Site

You have been asked to take part in this research study because you are listed on the Los Angeles County Cancer Surveillance Program’s registry as having been diagnosed with prostate cancer.  The Los Angeles Cancer Surveillance Program, is a member of the California Cancer Registry, which was created by the California Legislature in response to public concern that not enough was being done to find the causes and cures of cancer.  Every cancer diagnosed in California is required by law to be reported to the California Department of Health Services, which is responsible for the registry.  Information on individuals with cancer can only be released for research purposes to qualified researchers who have obtained approval for the study from a federally approved Committee for the Protection of Human Subjects, and have agreed to maintain the confidentiality of the information they collect.

About 2500 other patients will also be invited to participate in this study.  The purpose of this study is to look at characteristics such as race and where treatment was obtained and the impact these characteristics have on how well a patient does after they have been diagnosed and treated for prostate cancer. It is expected that it will take you 10 minutes to complete study related materials. Once study materials are completed no further participation is required on your part.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 2, 2008 at 2:51:04 PM